2
5th Annual Trendlines Company Showcase Shefayim, Israel • January 28, 2015 Medical Track Panelists Robert L. Grossman CoChair, Israel Practice Greenberg Traurig Robert (Bob) Grossman is an M&A and securities attorney with a wide range of experience taking companies public, handling private offerings, acquiring and selling companies, and advising businesses. His clients include many companies in the medical device, pharmaceutical, biotechnology, digital healthcare and healthcare industries, among others. Representative life science clients include and have included Teva Pharmaceutical Industries, IVAX Pharmaceuticals, OPKO Health, The Frost Group, Prolor Biotech, Oppenheimer & Co., Galmed Pharmaceuticals, Glasses Off, Ramsay HMO, Integrity Applications, Scivac, Biolight, Safestitch Medical (now Transenterix), Labstyle Innovations, and many others. In addition to representing Israeli companies, Bob and the firm’s Israel Practice Group provide assistance to Israeli and U.S. companies through introductions to strategic partners. Limor Sandach Venture Partner Access Medical Ventures Limor Sandach has over 18 years of extensive handson experience with Israeli health care companies. From inception to late stages, she is highly skilled in planning commercial strategies, business development, strategic alliances, and fundraising. She is a venture partner at Access Medical Ventures (AMV), a U.S.based VC fund focusing on earlystage health care companies. She manages AV Medical, one of AMV’s portfolio companies. Prior to AMV, Limor was a partner at 7 Health Ventures, an Israeli VC fund focused on investments in medical devices, and a principal at Evergreen Venture Partners, focusing on health care investments. She began her career at Naiot Venture Accelerator. Limor holds a master’s of engineering from the TechnionIsrael Institute of Technology. Zeev Zehavi VP, Venture Investments J&J Development Corp. At J&J Development Corporation, Zeev Zehavi is responsible for venture capital investments in Europe and Israel. Zeev’s background covers an extensive array of health care and health care related businesses. He spent over 10 years with Teva Pharmaceuticals, including a fiveyear assignment as president of the bulk chemical business in North America. Following the experience with Teva in the United States, Zeev returned to Israel to work with Clal Industries, one of the largest investment companies in Israel. He served as president of Clal Pharmaceutical Industries for four years. Fluent in Hebrew, English, and Arabic, Zeev received his MBA in marketing and finance from Tel Aviv University and his B.Sc. from Hebrew University of Jerusalem.
